QA: JOHNSON & JOHNSON in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2018_JOHNSON_JOHNSON.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000200406, JOHNSON & JOHNSON

  xvar xval
0 AssetsCurrent 43,088,000,000
1 IntangibleAssetsNetIncludingGoodwill 85,134,000,000
2 PropertyPlantAndEquipmentNet 17,005,000,000
3 remainder_Assets 12,076,000,000
4 LiabilitiesCurrent 30,537,000,000
5 LiabilitiesNoncurrent 39,692,000,000
6 remainder_Liabilities 26,914,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,420,000,000
9 ResearchAndDevelopmentExpense 10,554,000,000
10 remainder_Expenses 43,378,000,000
11 remainder_Revenues 76,450,000,000
12 remainder_NetIncome 202,000,000
13 remainder_ComprehensiveNetIncome 1,702,000,000
  yvar yval
0 Assets 157,303,000,000
1 Liabilities 97,143,000,000
2 Expenses 75,352,000,000
3 Revenues 76,450,000,000
4 StockholdersEquity 60,160,000,000
5 NetIncome 1,300,000,000
6 ComprehensiveNetIncome 2,151,000,000
7 BaseVar 204,076,000,000
8 EconomicCapitalRatio 0.830

Edgar->Model Mapping

Feature Distribution

Change over Time